DualVis

The first and only DMC HA preparation indicated for the treatment of knee osteoarthritis and is able to increase patient satisfaction because:

• Offers a dual concept solution (DMC-HA), as LUBRICANT as well as SHOCK ABSORBENT.
• Prevents disease PROGRESSIVITY by inhibiting the progression of cartilage degradation and bone destruction.
• Provides high comfort because the volume is only 1.4 ml and uses a 25G needle so as to minimize the risk of inflammation.
• “Cost-effective” only 2 injections for 2 years of efficacy, longer than a single HA product (LMW or HMW).